DelBello, M. P., Findling, R. L., Huss, M., Necking, O., Petersen, M. L., Schmidt, S. N., & Rosen, M. (2025). Vortioxetine in children and adolescents with major depressive disorder: 6-month and 18-month open-label, flexible-dose, long-term extension studies. European Child & Adolescent Psychiatry, 34(4), 1425. https://doi.org/10.1007/s00787-024-02560-1
Chicago Style (17th ed.) CitationDelBello, Melissa P., Robert L. Findling, Michael Huss, Oscar Necking, Maria L. Petersen, Simon N. Schmidt, and Monika Rosen. "Vortioxetine in Children and Adolescents with Major Depressive Disorder: 6-month and 18-month Open-label, Flexible-dose, Long-term Extension Studies." European Child & Adolescent Psychiatry 34, no. 4 (2025): 1425. https://doi.org/10.1007/s00787-024-02560-1.
MLA (9th ed.) CitationDelBello, Melissa P., et al. "Vortioxetine in Children and Adolescents with Major Depressive Disorder: 6-month and 18-month Open-label, Flexible-dose, Long-term Extension Studies." European Child & Adolescent Psychiatry, vol. 34, no. 4, 2025, p. 1425, https://doi.org/10.1007/s00787-024-02560-1.